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Muscle cells have a remarkable capability to repair
plasma membrane lesions. Mutations in dysferlin
(dysf) are known to elicit a progressive myopathy in
humans, probably due to impaired sarcolemmal
repair. We show here that loss of Dysf and annexin
A6 (Anxa6) function lead to myopathy in zebrafish.
By use of high-resolution imaging of myofibers in
intact animals, we reveal sequential phases in sarco-
lemmal repair. Initially, membrane vesicles enriched
in Dysf together with cytoplasmic Anxa6 form a tight
patch at the lesion independently of one another. In
the subsequent steps, annexin A2a (Anxa2a) fol-
lowed by annexin A1a (Anxa1a) accumulate at the
patch; the recruitment of these annexins depends
on Dysf and Anxa6. Thus, sarcolemmal repair relies
on the ordered assembly of a protein-membrane
scaffold. Moreover, we provide several lines of
evidence that the membrane for sarcolemmal repair
is derived from a specialized plasma membrane
compartment.
INTRODUCTION
Because of mechanical stress, skeletal muscle cells are particu-
larly prone to plasma membrane lesions (McNeil and Khakee,
1992). As a consequence, myofibers possess highly efficient
membrane repair, which prevents cell death and circumvents
costly muscle remodeling. The resealing process is proposed
to rely on the generation of a newmembrane barrier from internal
membrane compartments (Glover and Brown, 2007; Han and
Campbell, 2007). Important insight into the sarcolemmal repair
was gained by the identification of DYSF as an essential compo-
nent in the injury response. Mice deficient in DYSF develop
healthy muscles but exhibit progressive muscular dystrophy in
postnatal life (Bansal et al., 2003). Similarly, humans with muta-
tions in the DYSF gene acquire limb-girdle muscular dystrophy
type 2B (LGMD2B) (Bashir et al., 1998; Liu et al., 1998), Miyoshi
myopathy (Liu et al., 1998), or distal myopathy with anterior tibia-
lis onset (Illa et al., 2001). DYSF is a large (237 kDa in humans)
membrane protein, suggested to be also associated with cellularDevelovesicles (Klinge et al., 2010; Klinge et al., 2007). DYSF accumu-
lates at the site of membrane lesion in cultured cells and has
been proposed to be required for restoring cell integrity (Bansal
et al., 2003; Klinge et al., 2007).
Annexins form a large protein family, characterized by their
capability to bind phospholipids in a Ca2+-dependent manner.
Monomeric annexins can associate into multimeric complexes.
The known functions of annexins include directing Ca2+-regu-
lated exocytosis or endocytosis and stabilizing various
membrane compartments (Gerke et al., 2005). ANXA1 and
ANXA2 were shown to bind to Dysf (Lennon et al., 2003). It has
been hypothesized that the ability of annexins to form semicrys-
talline matrixes on artificial membrane surfaces in vitro could
facilitate plasma membrane resealing (Bouter et al., 2011).
Numerous cell types have been shown to be capable of
membrane repair (Glover and Brown, 2007; Han and Campbell,
2007). The visualization of this remarkably dynamic process
has thus far been carried out only in cell culture-based systems
with limited kinetic data (Cai et al., 2009a; Klinge et al., 2007;
McNeil et al., 2006; Reddy et al., 2001). Myofibers represent
a highly specialized cell type with distinct plasma membrane
compartments (T-tubules), membrane-localized as well as cyto-
plasmic proteins (i.e., caveolin 3 [CAV3], ANXA6), and higher
expression levels of genes involved in membrane resealing
(DYSF) (Anderson et al., 1999; Farber et al., 2003; Way and
Parton, 1995). Here, we have developed a high-resolution
imaging method to visualize the damage response of myofibers
in zebrafish muscles in real time. We demonstrate sequential
steps in plasma membrane patch formation and provide
evidence for a specialized membrane compartment for sarco-
lemmal repair.
RESULTS
Zebrafish Models for Dysferlinopathy
In order to establish the function of Dysf in zebrafish, we used
RACE-PCR to isolate the full-length coding sequence. We
carried out in situ hybridization and found dysf to be widely
expressed in zebrafish muscles (see Figure S1A available
online). To generate zebrafishmodels for Dysf deficiency-related
myopathies, we designed and tested six morpholinos against
exon/intron boundaries and one against the start codon. Of
thesemorpholinos, two led to a specific phenotype and changes
in Dysf transcript (Figures 1A, 1M, and 1N; Figures S1K–S1L).
Embryos injected with i36e37 morpholino developed eitherpmental Cell 22, 515–529, March 13, 2012 ª2012 Elsevier Inc. 515
Figure 1. Zebrafish Models for Dysferlinopathy
(A) Comparison of dysf morpholino-injected (i36e37, e18i18) embryos with uninjected control (first panel) at 72 hpf. The i36e37 morphants have slightly bent
(second panel) or curved body (third panel), whereas e18i18 morphants (fourth panel) have dorsally bent trunks.
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Imaging Sarcolemmal Repaira curved (7/108) or a bent (40/108) trunk at 72 hours postfertiliza-
tion (hpf), and all (n = 108) acquired mild to severe cardiac
edema. The blood circulation was normal, and the heartbeat
was only slightly affected (Figure S1B). Slow muscle myosin
staining revealed only mild defects in myofiber development at
24 hpf (n = 60) but emergence of extensive gaps in the muscle
tissue by 72 hpf (all analyzed larvae, n = 60) (Figures 1B and
1C). Actin staining of deeper muscle sections confirmed the
broad distribution of muscle defects (Figure 1D). Myofibers often
crossed several layers, making use of cell-free spaces. The my-
oseptal angle inmorphants (111.7 ± 1.8) was different from that
of uninjected control larvae (83.5 ± 0.8) (Figure 1E; Figure S1C).
To find out whether Dysf knockdown leads to sarcolemmal
defects, we injected membrane-impermeable Evans blue dye
into the pericardiac sinus at 48 hpf. Imaging at 72 hpf demon-
strated accumulation of the dye in the muscle tissue in i36e37
morphants but not in control larvae (Figure 1F). The very severe
form of myopathy led to drastic and progressive loss of muscle
birefringence (all analyzed larvae at 72 hpf, n = 50) (Figure 1G;
Figure S1D–S1I). At the ultrastructural level, large gaps between
myofibrils could be observed (Figures 1H and 1I). T-tubules were
often misaligned and fragmented (Figure 1J). Accumulation of
vesicles and elongated membrane compartments could be de-
tected around myofibrils (Figure 1K).
The e18i18morpholino-injected larvae developed a bent trunk
by 72 hpf (98/100) (Figure 1A). The myofibers were slightly mis-
aligned (Figure 1D). However, no significant muscle damage
could be observed in the larvae, and the myoseptal angle
(85.3 ± 1.04) was indistinguishable from uninjected fish
(Figures 1B–1F; Figure S1C). We used mismatch control mor-
pholinos for both e18i18 and i36e37 and found no change in
comparison with uninjected larvae (n > 100; Figure S1J). Further-
more, a search in the zebrafish genome assembly did not reveal
similar target sequences in other genes. We conclude that the
phenotypes we observed are due to specific targeting of Dysf.
In silico protein domain prediction indicated that zebrafish
Dysf has seven C2 domains and four Dysf domains. A putative
transmembrane (TM) domain is located at the C-terminal end
of the protein (Figure 1L). To characterize the morpholino-
induced changes at the molecular level, RT-PCR was carried
out on total RNA, extracted from single larvae. The i36e37
morpholino leads to two different changes in dysf splicing (Fig-(B) Embryos at 24 hpf, stained with slow muscle myosin antibody F59. No signifi
(C) F59 staining at 72 hpf reveals gaps (arrow) in the muscles of i36e37 morphan
(D) Actin (FITC-phalloidin) staining demonstrates curved myofibers and gaps (arro
myofibers.
(E) b-sarcoglycan staining shows differences in myoseptal (arrowhead) angle in i
(F) Accumulation of Evans blue dye in i36e37 morphant muscle tissue (m). bv, bl
(G) Birefringence is drastically reduced in i36e37morphants at 72 hpf, whereas n
(H–K) Electronmicroscopy (sagittal sections) of 72 hpfmyofibers. Plasmamembra
aligned sarcomeres and T-tubules (arrows). (I) shows extensive muscle damag
morphant myofiber shows misplaced T-tubule fragments (arrows). In (K), vesicle
(L) Zebrafish Dysf protein structure: C2, C- and N-terminal Dysf (DC andDN) as we
(M) Sequence alignment of human and zebrafish Dysf C2E domain (underlined). Th
letters outline the region, which is missing in i36e37morphants. Additional transc
from the morpholino target site. Asterisks indicate mismatch substitutions that c
codon in human DYSF.
(N) Sequence alignment of the Dysf protein region targeted by e18i18 morpholino
embryos A–G: anterior left, dorsal up.
Scale bars represent 500 mm (A and G); 80 mm (B, C, E, and F); 20 mm (D); 6 mm
Develoure S1K). First, the morphants have a transcript with the addition
of intron 36, resulting in a premature stop codon and a protein,
missing the three C-terminal C2 domains (C2E–C2G) and the
TM domain (Figures 1L and 1M). The second transcript lacks
two exons (37 and 38), causing an 80-amino acid (80-aa) deletion
and removing a large part of the C2E domain (Figure 1M).
Missense mutations in the C2E domain and the surrounding
area have been found in patients to cause either LGMD2B or
Miyoshi myopathy due to downregulation or aggregation of
DYSF (Figure 1M) (De Luna et al., 2007; Guglieri et al., 2005; Ka-
wabe et al., 2004; Krahn et al., 2009; Nguyen et al., 2005; Nguyen
et al., 2007; Wenzel et al., 2006). Remarkably, the C2E domain
displays a high level of evolutionary conservation (Figure 1M),
supporting its importance for Dysf function. The e18i18morpho-
lino leads to a 26-aa deletion in Dysf (Figure 1N; Figure S1L). The
area lies outside of known protein domains but is evolutionarily
very highly conserved (92.6%) between zebrafish and human
(Figure 1N). Curiously, three missense substitutions have been
found in this short fragment to cause myopathy (Cagliani et al.,
2005; Illa et al., 2007; Krahn et al., 2009). Altogether, our data
indicate that lack of Dysf leads to severe myopathy in zebrafish.
Rapid Relocation of Dysf to Membrane Lesions
We next focused on the analysis of the subcellular location of
Dysf. To gain a muscle-specific expression system, we charac-
terized the regulatory elements of the zebrafish unc45b gene
(Figures S2A–S2D). We examined Dysf subcellular localization
in myofibers by fusing monomeric teal fluorescent protein
(mTFP1) to its C terminus and expressing it under the unc45b
regulatory region. At low expression levels, Dysf-mTFP1 was
distributed at the T-tubule attachment sites at the sarcolemma
(Figure 2A), whereas at higher expression levels, it was detect-
able along the length of the sarcolemma and the T-tubules. We
tested which domain of Dysf is responsible for the membrane
localization by generating truncated Dysf proteins fused to
mTFP1 (Figure 2B). Neither DysfN, harboring the three
N-terminal C2 domains, the DysfCEN1 with the Dysf domains,
nor the DysfCEN2 with the four C-terminal C2 domains resulted
in accumulation of mTFP1 at membranes. In contrast, the frag-
ment DysfC, containing the TM domain, flanked by 29 aa on
the cytoplasmic side and 22 aa on the extracellular side was
located at the sarcolemma (Figures 2B; Figures S2E–S2F).cant defects were obvious in dysf morphants.
ts, whereas no defects were observed in e18i18 morphants.
w) in the i36e37morphant muscles. e18i18morphants have slightly misaligned
36e37 morphants.
ood vessel.
o difference was noted in e18i18morphants in comparison with control larvae.
ne is electron dense. (H) shows uninjected control larval myofiber with correctly
e in i36e37 morphant myofibers. In (J), a high-magnification image of i36e37
s (arrowheads) are widespread in damaged i36e37 morphant myofibers.
ll as the TM domain are indicated. Vertical lines point tomorpholino target sites.
e arrowhead points to the splice site, targeted by morpholino i36e37. Magenta
ript is present in the morphants, lacking the whole protein region, downstream
ause myopathy in humans; x denotes mutations, resulting in premature stop
. Letters in magenta indicate the deleted part in the morphants. Orientation of
(C); 2 mm (H–I); 1 mm (J and K). See also Figure S1.
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Figure 2. Characterization of Dysf and Its Response to Cell Lesions
Full-length Dysf or parts of it were fused to mTFP1 (green) and expressed in zebrafish. mCherry-CAAX marks cell membrane in magenta.
(A) At low expression levels (left), Dysf accumulates preferentially at the neck regions of T-tubules (arrowhead) but is more uniformly distributed along the plasma
membrane at higher levels (right).
(B) Domain architecture of Dysf and subcellular location of individual regions. mTFP1 was fused to the C terminus, except for the TM domain (DysfC construct),
where it was fused to the N-terminus. Only the C-terminal part of Dysf (DysfC) localizes to the plasma membrane.
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Imaging Sarcolemmal RepairDysf was suggested to have a prominent role in cell membrane
repair (Bansal et al., 2003), but its exact mode of function has re-
mained elusive. By using two-photon laser pulses, we generated
small sarcolemmal ruptures in 3- to 5-day-old zebrafish larvae.
This enabled us to visualize protein dynamics in the intact
muscle. We detected rapid Dysf-mTFP1 accumulation at the
sarcolemmal lesion (Figure 2C). The accumulation did not
depend on Dysf-mTFP1 expression level nor on the size of lesion
(Figure 2D). Dysf appears to arrive at the site of damage on the
surface of vesicular membrane structures (Figure 2C, insert).
Given that Dysf-mTFP1 is primarily localized at the T-tubules
and sarcolemma in undamaged myofibers, our results suggest
that membrane for repair derives from the plasma membrane.
Moreover, the TM and the flanking 29 N-terminal aa and 22
C-terminal aa (DysfC construct) appear to be sufficient for allo-
cation to this compartment (Figure 2C). The C-terminal 22 aa
stretch by itself does not show relocation in injured cells (Fig-
ure S2G). The N-terminal C2 domain of mammalian Dysf can
interact with lipids in vitro (Therrien et al., 2009). We did not
find significant membrane binding of the DysfN-mTFP1 frag-
ment, nor did this Dysf variant accumulate in the lesion in our
in vivo assay (Figure 2C). This underscores the importance of
membrane insertion of Dysf in the resealing process.
We observed accumulation of the DysfCEN2 but not
DysfCEN1 fragment at the lesion (Figure 2C). The four C2
domains in the C-terminal half of mammalian Dysf, correspond-
ing to the DysfCEN2 fragment, did not show significant
Ca2+-dependent lipid-binding activities in vitro (Therrien et al.,
2009). Because the DysfCEN2 fragment does not contain the
TM domain, it is likely that it gets recruited into the repair patch
in a complex with the full-length Dysf. Indeed, purified GST-
tagged DysfCEN2 protein could interact with purified recombi-
nant DysfCEN2-His (Figures 2E–2G).
Dysf Defines a Damage-Responsive Membrane
Compartment
The origin of the membrane that myofibers use for sarcolemmal
resealing has remained an open question. The accumulation of
the sarcolemma-localized Dysf at the site of lesion indicates
plasma membrane source for the repair compartment. This rai-
ses the questions of whether any part of the plasma membrane
can be used for sarcolemmal repair and whether there are
specific Dysf-enriched microdomains (Figures 3A and 3B). Fluo-
rescence recovery after photobleaching (FRAP) has widely been
used to study the diffusion ofmembrane proteins in lipid bilayers.
The comparison between the recovery rates of mCherry-CAAX
andmOrange1-DysfC after photobleaching of undamaged myo-
fibers illustrates highly similar kinetics of diffusion and
membrane association for the two proteins (Figure 3C). Next,
the membrane markers caveolin 3 (Cav3), SNAP23 (Soluble(C) Response of Dysf, Dysf N-terminal domain (DysfN), DysfCEN1, DysfCEN2, a
Vesicular structures are visible at high magnification (insert). Although DysfN and
and DysfC.
(D) Dysf accumulation at the site of damage in a cell with a low expression level
(E) Purified DysfCEN2-GST (arrowhead) and glutathione S-transferase (GST) pro
(F and G) Protein pull-down experiment with recombinant GST- and His-tagged
stained with anti penta-His antibody. DysfCEN2-His (97kDa, black arrow) was pull
section shows 20% of His-tagged protein input.
Scale bars represent 4 mm (A–D) and 0.4 mm (C insert). See also Figure S2.
DeveloNSF Attachment Protein 23) and mCherry-CAAX were studied
in damaged myofibers. None of them showed significant accu-
mulation in the lesion (Figures 3D and 3E; Figure S2G). In
contrast, a nearly 2-fold increase of mTFP1-DysfC fluorescence
(183 ± 14% at 210 s) was noted at the site of membrane rupture.
The plasma membrane has specific Dysf-enriched regions that
are rapidly mobilized and recruited to the damaged sarcolemma.
Studies of cell culture models predicted a role for different
exocytic or endocytic vesicles in membrane repair (Idone et al.,
2008; Reddy et al., 2001). We therefore analyzed whether vesi-
cles involved in cell homeostasis could provide membrane for
patch formation. We generated fusion proteins for characteristic
markers of various membrane transport steps (Schwartz et al.,
2007). The three zebrafish lysosome-associated membrane
proteins—Laptm4a (lysosome-associated protein transmem-
brane 4a) and Lamp1 and Lamp2 (lysosome-associated
membrane proteins 1 and 2)—did not accumulate in the lesion
(Figures 3F; Figures S3A–S3D). Only when the damage was
induced close to a lysosome was it incorporated in the repair
patch (Figure S3D). None of the studied Rab-GTPases (Rab1a,
Rab5a, Rab6a, Rab7, Rab12, and Rab27a) showed a significant
increase at the sarcolemma close to the rupture, nor did they
clog the lesion (Figure 3F; Figure S3E). Dysf was shown to be
rapidly endocytosed through syntaxin4 (STX4) positive com-
partments (Evesson et al., 2010). We found no mTFP1-Stx4
accumulation at the lesion, which indicated that Stx4-mediated
endocytosis is not directly involved in sarcolemmal repair (Fig-
ure 3F). In summary, our analysis of various cytoplasmic vesicle
markers does not show amajor involvement of cytoplasmic vesi-
cles in providing membrane for the resealing of the sarcolemmal
rupture.
Annexin Scaffold in Sarcolemmal Lesion
Annexins (A1, A2, A5, A6) have been shown to enhance plasma
membrane resealing in diverse cultured cell types (Bouter et al.,
2011; McNeil et al., 2006; Potez et al., 2011). Anxa6 and anxa11a
were shown to be expressed in zebrafish muscle (Farber et al.,
2003). In addition, we detected expression of anxa1a and anxa2a
transcripts in muscle (Figure S4A). RT-PCR of adult zebrafish
muscle samples indicated high levels of anxa1a, anxa2a, and
anxa6 mRNA, whereas anxa11a mRNA is present at a very low
level (Figure S4B). Anxa1, Anxa2, and Anxa6 are also expressed
in mammalian skeletal muscle (Bizzarro et al., 2010; Draeger
et al., 2003; Lennon et al., 2003), indicating evolutionary conser-
vation of expression.
Anxa1a, Anxa2a, Anxa6, and Anxa11a fusedwith mTFP1were
detectable throughout the cytoplasm inmyofibers of 3- to 5-day-
old larvae (Figure S4C), which is in good agreement with the
cytoplasmic localization of fluorescently labeled annexins
(ANXA1 and ANXA5) in cultured mammalian myoblasts andnd DysfC to membrane lesions (arrow). Dysf accumulates at the site of lesion.
DysfCEN1 do not accumulate in the lesion, there is an increase of DysfCEN2
of the fusion protein.
teins on SDS PAGE gel.
proteins. (F) shows an anti-GST stained western blot; (G) shows the same blot
ed down by DysfCEN2-GST but not with GST alone or sepharose beads. Lower
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Figure 3. Origin of the Repair Membrane
(A and B) Schematic representation of the two possible sources of the sarcolemmal resealing membrane. (A) Random plasma membrane fragments, decorated
with mCherry-CAAX (magenta) or Dysf (green) could provide substrate for membrane repair. (B) Specific Dysf-enriched membrane domains exist for resealing
of lesions.
(C) FRAP experiment with mOrange1-tagged DysfC and mCherry-CAAX show comparable kinetics in undamaged myofibers.
(D) The TM domain of Dysf (DysfC) accumulates rapidly at the site of lesion. Much slower or no accumulation was observed for mCherry-CAAX, mTFP1-SNAP23
and Cav3-mTFP1.
(E) Coexpression of mTFP1-DysfC and mCherry-CAAX. In contrast to mTFP1-DysfC (green), mCherry-CAAX (magenta) does not accumulate in the lesion.
(F) Visualization of Lamp1-mTFP1, mTFP1-Rab1a, mTFP1-Rab5a, mTFP1-Rab6a, mTFP1-Rab7, mTFP1-Rab12, mTFP1-Rab27a, and mTFP1-Stx4 localization
(green) in uninjured and injured cells. No significant relocation of the studied vesicle markers could be observed. mCherry-CAAX marks the cell membrane in
magenta. White arrow indicates damaged sarcolemma.
Scale bars represent 3 mm (E) and 4 mm (F). See also Figures S2 and S3.
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Figure 4. Annexin Kinetics in Myofibers
(A) Comparative relocation kinetics of annexins. Green letters in name or pie graph sector denote annexin taggedwithmTFP1, andmagenta letters indicate fusion
to mOrange1. The pie graph illustrates relative intensity of the two fluorophores in the lesion. Anxa6 and Anxa11a are the fastest to accumulate in the wound,
followed by Anxa2a and Anxa1a.
(B) Kinetics of mTFP1-tagged annexins at the site of the lesion (mean from eight experiments). Anxa6-mTFP1 showed a rapid increase in the lesion, whereas
a time delay was observed for other annexins.
(C) FRAP was carried out with annexins tagged with mOrange1 (mean of 25 experiments). The motility of different annexins in the cytoplasm is comparable.
(D) Domain architecture of zebrafish annexins. Green boxes denote Ca2+-sensitive domains. Sizes are proportional to sequence length.
(E) Accumulation of mutant Anxa6, missing the 4 C-terminal Ca2+-sensing domains, is impaired in comparison with full-length Anxa6; compare with the Anxa6
panel in (B).
Scale bars represent 4 mm. See also Figure S4.
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Imaging Sarcolemmal Repairmyotubes (Bizzarro et al., 2010; Cai et al., 2009a). We found that
paraformaldehyde fixation induced rapid relocation of annexins
to the sarcolemma (Figure S4D) similarly to membrane associa-
tion of ANXA1 and ANXA2 upon immunohistochemistry on tissue
sections (Lennon et al., 2003). Annexins were shown to accumu-Develolate at damaged cell membrane (Bouter et al., 2011; Cai et al.,
2009a; McNeil et al., 2006; Potez et al., 2011), and we confirmed
such behavior in zebrafish myofibers (Figures 4A; Figure S4E).
Small wounds (less than the length of a sarcomere, < 2 mm) at-
tracted less annexin, and the annexin patch was resolved withinpmental Cell 22, 515–529, March 13, 2012 ª2012 Elsevier Inc. 521
Figure 5. Distribution of Annexins in the Lesion and the anxa6 Morphant Phenotype
(A) FRET was carried out to map the spatial distribution of annexins at high resolution. The lower triangle demonstrates FRET signal (designated as F), upper
triangle and lower panel (surrounded by boxes) show the extent of damage by the colocalization of the two proteins. In each panel, the combination of annexins
coexpressed are indicated by numbers (1: Anxa1a; 2: Anxa2a; 6: Anxa6; 11: Anxa11a), and the color identifies the fusion to mTFP1 (green) or mOrange1 (orange).
(B) Control of FRET experiments. No FRET (left) when mOrange1 and mTFP1 were coexpressed without fusion to annexins. Overlay of mOrange and mTFP1 is
shown on the right.
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Imaging Sarcolemmal Repairminutes (Figure S4F), whereas large wounds led to long-lasting
annexin membrane binding (Figure S4G). We explored whether
there were differences in the kinetics of accumulation of annex-
ins at the lesion. Testing pairwise comparisons between mTFP1
and mOrange1 tagged proteins, we found that Anxa6 and
Anxa11a were the fastest to accumulate at the lesion, whereas
Anxa2a and Anxa1a relocated more slowly, with the latter being
the slowest of the studied proteins (Figures 4A and 4B). On
average, Anxa1a started to accumulate after 200–240 s, Anxa2a
did so after 60–80 s, Anxa11a did so after 40 s, and no time delay
could be observed for Anxa6. The differential responses did not
depend on the size of the lesion or the abundance of a particular
tagged annexin (Figures S4H and S4I). For example, we did not
observe a significant correlation between the initial intensity of
Anxa2a and its rate of accumulation by 60 s (r = 0.28). Anxa6
always started to accumulate by 20 s, regardless of initial
expression level (n > 50). FRAP experiments did not reveal differ-
ences in annexin motility in undamaged myofibers (Figure 4C),
which indicates that the distinct dynamics are characteristic to
the proteins in injured cells. Similarly to human ANXA6 (Gerke
et al., 2005), and unlike other annexins, in silico domain predic-
tion supported the existence of eight Ca2+-sensing domains in
the zebrafish Anxa6 (Figure 4D). To confirm the requirement of
these domains for a fast lesion response, we generated mutant
Anxa6, lacking the four C-terminal Ca2+-sensing domains. The
truncated protein had significantly delayed response to sarco-
lemmal injury (Figure 4E), suggesting that differential sensitivity
to Ca2+may be one parameter that affects the speed of accumu-
lation at the site of damage.
Experiments with purified annexins have shown that they can
be aligned in a semicrystalline manner on artificial membranes
(Bouter et al., 2011; Buzhynskyy et al., 2009; Illien et al., 2010;
Lambert et al., 1997). We therefore tested whether such tightly
packed complexes of annexins could occur at the site of lesion
in vivo. We carried out fluorescence resonance energy transfer
(FRET) experiments with all four annexins fused either to
mOrange1 or mTFP1 to demonstrate the close placement of
these proteins at the site of lesion (Figure 5A). The energy trans-
fer distance, Fo¨rster radius (R0), was estimated to be 5.7 nm for
the mTFP1-mOrange1 fluorescent protein pair, indicative of
a tight packing of the proteins (Ai et al., 2006). FRET was
apparent not only between identical annexins but also between
different types of annexins (Figure 5A). We did not observe
FRET between annexins at sites distant to the lesion or before
cell wounding (data not shown). Differences in signal intensity
between different FRET pairs were evident (Figure 5C) and
were in direct correlation with the arrival kinetics of annexins(C) Quantitative analysis of FRET signal intensity in the lesion (mean of five expe
(D) Injection of anxa6 morpholino leads to curved trunk by 3 days of developmen
(E and F) Slow muscle myosin staining (F59 antibody) shows largely normal mus
72 hpf (F).
(G) Deeper muscle sections were visualized with phalloidin-stained actin. Curved
(H) b-sarcoglycan staining of obtuse myoseptal angles.
(I) Only very few cells (arrowhead) in the muscle tissue of anxa6 morphants beca
(J) Birefringence is only moderately affected in anxa6 morphants.
(K–M) Electronmicroscopy of anxa6morphant myofibers. Cell membrane is electr
occasional damage could also be detected (L, arrows). (M) shows accumulation o
(D–J): anterior left, dorsal up.
Scale bars represent 6 mm (A and B); 500 mm (D and J); 80 mm (E, F, H, and I); 20
Develoat the site of lesion: the more rapidly accumulating Anxa11a,
Anxa6, and Anxa2a resulted in strong FRET signals.
Anxa6 Deficiency Leads to Myopathy
Because Anxa6 responds rapidly tomyofiber damage, we tested
its requirement in maintaining muscle integrity. We designed a
morpholino, which led to a premature stop codon resulting in
a truncated protein (177 aa protein in comparison with 662 aa
wild-type [WT] Anxa6) (Figure S1M). Knockdown of Anxa6, simi-
larly to the dysf i36e37 morphants, resulted in a curved trunk in
3-day-old larvae (44/101) (Figure 5D). Early muscle development
was not significantly affected (n = 30) (Figure 5E). However, gaps
between myosin-stained slow muscle cells, as well as among
actin-stained deeper myofibers, were evident at 72 hpf in all
analyzed larvae (n = 60 for both myosin- and phalloidin-stained
actin) but were more limited than in the dysf i36e37 morphants
(Figures 5F and 5G). The myoseptal angle (110.6 ± 1.2) was
significantly wider than that in uninjected control larvae
(83.5 ± 0.8) (Figure 5H; Figure S1C). On the other hand, only
few cells had become permeable to Evans blue dye (Figure 5I).
In contrast to the dysf i36e37 morphants, we noted a smaller
reduction in birefringence (Figure 5J). Electron microscopy
demonstrated largely intact myofibers in anxa6 morphants,
with occasional cell damage (Figures 5K and 5L). Vesicles could
be detected under the sarcolemma (electron dense) of ruptured
myofiber (Figure 5M). Taken together, the effects of knockdown
of Anxa6 are similar to but overall weaker than those of dysf
i36e37 morphants. Larvae injected with mismatch control mor-
pholino had a WT phenotype (n > 100; Figure S1J).
Cumulative Role for Anxa6 and Dysf in Myofiber
Maintenance
Simultaneous knockdown of Dysf (i36e37 morpholino) and
Anxa6causedamoreseverephenotype thanknockdownofeither
of the proteins separately. All the analyzed double-morphants
hadacurved trunk (n>100) andseverecardiacedema (Figure6A).
Muscle birefringence was almost completely absent (Figure 6B).
Large cell-free spaces and severe misalignment of the myofibers
could be observed (Figure 6C). The data suggest that the two
proteins share functional aspects. Indeed, DysfC and the fastest
annexin, Anxa6, accumulated simultaneously at the lesion (Fig-
ure 6E) with similar kinetic curves (compare Figures 3D and 4B).
They also have the same spatial distribution at the lesion: the
edges of the sarcolemmal lesion attracted initially both Dysf and
Anxa6, from where the patch spread over the rupture (Figure 6E).
In order to analyze sarcolemmal damage induced changes at
ultrastructural level, we screened for chemicals that could triggerriments).
t.
cle development at 24 hpf (E), but reveals gaps (arrows) between myofibers at
myofibers and gaps (arrows) were evident.
me penetrable to Evans blue dye. bv, blood vessel.
on dense. In large areas, proper myofibril organization was present (K), whereas
f vesicles (arrowheads) at the site of myofiber damage. Orientation of embryos
mm (G); 2 mm (K and L); 1 mm (M). See also Figure S1.
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Figure 6. Anxa6/Dysf Double Morphant, Anxa6/Dysf Coexpression, and Ultrastructural Characterization of Muscle Damage
(A) Anxa6 and dysf (dysf i36e37) double morphants have curved body and severe cardiac edema (arrowhead) at 72 hpf.
(B) Muscle birefringence is almost completely absent.
(C) Misalignment (asterisks) and gaps between myofibers are visible by actin staining in the double morphants.
(D) Actin staining demonstrates normal myofiber alignment in uninjected control larvae.
(E) The accumulation of mTFP1-Dysf-coated membrane at the lesion (arrow) is rapid and coincides with Anxa6-mOrange1 appearance at the damaged
sarcolemma. Increased fluorescence is depicted by lighter colors and higher surface plot profile. Note that the initial accumulation appears at the edges of the
sarcolemma, from where it spreads over the damaged area, which is eventually sealed (arrowhead).
(F–N) Electron microscopy of 72 hpf myofibers. In (F), veratridine treatment leads to vesicle (arrowhead) accumulations under the sarcolemma in WTmyofiber. In
(G), high-magnification is shown of the boxed area in (F). In (H), cytoplasmic vesicles (arrowhead) often arise close to T-tubules (arrow). In (I), membrane blebbing
and vesicles (arrowheads) could be observed at sites of fiber rupture. In (J), veratridine treatment leads to extensive muscle damage in anxa6morphants. Large
vacuolar structures (arrowheads) can be seen around ruptured myofibers. In (K), veratridine treatment enhances muscle damage in dysf i36e37 morphants. In
some areas, correct sarcomeric filament alignment was evident (C2), whereas in other areas, it was significantly impaired (C1) or completely absent (C3).
(L) High-magnification image of veratridine-treated dysf i36e37morphant muscle demonstrates misaligned sarcomeres, accumulation of vesicles (arrowhead) in
the cytosol and T-tubule damage (arrows). The insert shows a magnified area (1 3 1 mm).
(M and N) Anxa6 and dysf double morphants have severe muscle damage in untreated (M) and veratridine-treated (N) conditions. Membrane blebbing and
vesicles (arrowheads) could be detected at sites of cell rupture after veratridine treatment. Orientation of embryos in (A–D): anterior left, dorsal up.
Scale bars represent 500 mm (A and B); 20 mm (C and D); 1.6 mm (E); 2 mm (F, G, and J–M); 1 mm (H, I, and N).
Developmental Cell
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contractility occur during cramping, which led us to hypothesize
that sarcolemmal ruptures could be frequent. Veratridine leads
to an increase of Na+ and Ca2+ ions in muscles (Gissel and Clau-524 Developmental Cell 22, 515–529, March 13, 2012 ª2012 Elseviersen, 1999) and is a potent inducer of cramps in zebrafish. Electron
microscopy of veratridine-treated larvae demonstrated mostly
intact myofibers. Vesicle accumulation was occasionally ob-
served under the sarcolemma (electron dense) (Figures 6F–6H).Inc.
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blebs and vesicles were obvious (Figure 6I). We asked whether
Anxa6 or Dysf knockdown could influence muscle response to
cramp-induceddamage. Anxa6morphants developed a vacuolar
type myopathy in response to veratridine administration. The
sarcolemmal ruptures thatwereobserved inuntreatedanxa6mor-
phants (Figures 5L and 5M) were significantly more prevalent on
veratridine treatment (Figure 6J). Largemembrane compartments
were detected not only at the site of cell damage but also else-
where between the myofibers. Dysf morphants developed also
a more severemyopathy when exposed to veratridine. Myofibers
demonstrated thick and thin filamentmisalignment. T-tubule frag-
mentation and extensive accumulation of vesicles were common
(Figure 6K and 6L). Widespread muscle damage was evident in
both untreated and veratridine-treated anxa6 and dysf double
morphants (Figures 6M and 6N).
Sequential Stages in Sarcolemmal Damage Response
To establish the mechanism by which Dysf and Anxa6 influence
cell membrane repair, we combined morpholino experiments
with quantitative intravital imaging. Knockdown of Dysf
(i36e37), Anxa6, or both together abolished Anxa1a accumula-
tion (Figures 7A–7C). In a similar manner, Anxa2a accumulation
was significantly perturbed. Anxa2a reached predamage fluo-
rescence intensity at the site of lesion by 40–80 s in control larvae
and by 120–200 s in dysf i36e37 morphants (Figure 7D). The
accumulation of Anxa2 was even more impaired in anxa6
morphants and almost completely absent in dysf/anxa6 double
morphants (Figures 7E and 7F). Furthermore, the morphology
of the repair patch differed in the morphants. The Anxa2a patch
outlined loosely packed membrane compartments (diameter up
to 6 mm) that failed to generate a dense patch (Figures 7G and
7H). The large membrane blebs are similar to those observed
in veratridine-treated anxa6 morphants (Figure 6J). Knockdown
of both proteins led to diffusion of Anxa2a-mTFP1 through the
sarcolemmal rupture out of the cell (Figure 7I). In somemyofibers
(2/8), large vesicles appeared near the lesion but failed to
generate a dense patch (Figure 7J). The specificity of the mor-
pholinos was confirmed by the analysis of embryos injected
with 5 base pair (bp) mismatch control morpholinos. The control
morpholino did not alter repair patch formation: Anxa2a-mTFP1
accumulated within 80 s, and the resulting patch was a tightly
packed structure as in WT fish (Figures S5A, S5B, S5D, and
S5E). Moreover, mOrange1-tagged full-length Dysf was capable
of rescuing Anxa2a-mTFP1 accumulation in the dysf i36e37mor-
phants, and Anxa6-mOrange1 was sufficient to rescue the patch
formation in anxa6 morphants. Rapid accumulation of Anxa2a
occurred after 80 s in rescued myofibers (Figures 7K and 7L;
Figures S5F and S5G). In contrast, the short DysfC construct
was incapable of rescuing the Anxa2a patch formation in dysf
i36e37 morphants, and the truncated Anxa6, lacking the 4
C-terminal Ca2+-sensitive domains, was similarly inefficient in
rescuing the patch formation in the anxa6morphants (Figure 7M;
note the delayed accumulation). These experiments indicate the
specificity of the rescue experiments and point to the require-
ment for full-length proteins in this process. In contrast to the
dysf i36e37 morphants, the patch formation occurred similarly
to uninjected fish in the dysf e18i18 morphants (Figures S5C
and S5H).DeveloIntriguingly, Dysf knockdowndidnot inhibit earlyAnxa6 recruit-
ment to the lesion (Figure 7N), nor was the rapid accumulation of
DysfC-labeled membrane perturbed in the Anxa6 morphants
(Figures 7O and 7Q). Likewise, the full-length Dysf was enriched
at the T-tubule attachment sites at the sarcolemma in the anxa6
morphants and responded to membrane damage (Figure 7R).
These data imply independent redistribution of theDysf-enriched
membrane and Anxa6. We detected DysfC-labeled membrane
accumulation in the lesion of dysf morphants (Figures 7P and
7S). Although Dysf is enriched in a particular membrane domain,
it does not appear to be essential for the generation of such
membrane structures at the early stages of sarcolemmal repair
or its transport to the lesion. Finally, on the basis of RAB27A up-
regulation in DYSF-deficient human myofibers, it was hypothe-
sized that RAB27A may have a compensatory role (Kesari et al.,
2008). However, mTFP1-Rab27a did not accumulate in the
sarcolemmal rupture of dysf i36e37 morphants, implying no
significant contribution from this vesicle pool (Figure 7T).
DISCUSSION
We describe here zebrafish models for dysferlinopathy. Dysf
knockdown does not significantly impair muscle development
but, nonetheless and in contrast to the mouse model (Bansal
et al., 2003), results in early myopathy. In comparison with dysf
i36e37 morphants, anxa6 morphants show a milder phenotype.
Similarly, Dysf/ mice develop a more severe myopathy in
contrast with the minor abnormalities in Anxa6/ mice (Bansal
et al., 2003; Hawkins et al., 1999; Song et al., 2002). Both
mammalian DYSF and ANXA6 were shown to enhance cell
recovery frommembranedamage in vitro (Bansal et al., 2003; Po-
tez et al., 2011), in agreement with our findings in zebrafish.What
could explain the more severe phenotype of dysf morphants?
There are three annexins in mature myofibers, and although we
found different kinetics of accumulation, they could still coop-
erate with Dysf to at least partially compensate for one another.
Because a cell-impermeable dye rapidly penetrated myofibers
in dysf morphants, it is likely that Dysf-deficient muscles are
more prone to membrane lesions. Extensive physical activity
evoked by veratridine treatment led to even more severe defects
in the dysfmorphants, outlining the general role for Dysf in main-
taining cell integrity. Such function does not appear to be limited
only to sarcolemmal repair but involves awider role in correctmy-
ofiber arrangement. In support of this, the e18i18morphants that
lack a small fragment of Dysf have curved trunk muscles without
abnormalities in repair patch formation. Similar to findings in
previous data (Klinge et al., 2010), T-tubule defects were
observed in Dysf knockdown myofibers, which is indicative of
a role in shaping and maintaining these membrane structures.
A comparable role was recently proposed for dystroglycan
(Gupta et al., 2011). T-tubules are particularly vulnerable to
muscle damage (Takekura et al., 2001), which is suggestive of
an enhanced repair protein requirement.
A Specialized Membrane Compartment for
Sarcolemmal Repair
The origin of the membrane that is used in sarcolemmal repair
has remained elusive. Dysf was shown to accumulate at the
site of membrane lesion in cultured myoblasts (Klinge et al.,pmental Cell 22, 515–529, March 13, 2012 ª2012 Elsevier Inc. 525
Figure 7. Functional Interactions in Repair Patch Formation
(A–I) Anxa1a accumulation is impaired in dysf i36e37morphants (A), anxa6morphants (B) and dysf/anxa6 double morphants (C). Anxa2a-mTFP1 accumulation is
delayed in dysf i36e37 morphants (D), severely perturbed in anxa6 morphants (E) and impaired in dysf/anxa6 double morphants (F). The repair patch (arrow)
morphology at the 3 min time point after damage (as illustrated by Anxa2a-mTFP1) is severely affected in dysf i36e37morphants (G) and in anxa6morphants (H).
Anxa2a diffuses out of the cell at the 3 min time point after membrane rupture (arrow) without aggregating into a patch in double morphants (I).
(J) In a few cases, larger vesicles were visible in the double morphants.
(K) Full-length Dysf-mOrange1 rescues Anxa2a-mTFP1 recruitment in dysf i36e37 morphants.
(L) Anxa6-mOrange1 rescues Anxa2a-mTFP1 accumulation in anxa6 morphants.
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fiber lesion on the surface of vesicles. The membrane for repair
appears to arise from the plasma membrane to where Dysf is
localized. As general membrane proteins (mCherry-CAAX,
Cav3, SNAP23) did not show significant accumulation at the
lesion, it appears that sarcolemmal resealing depends on
a specialized plasma membrane compartment. The TM domain
of Dysf with 29 aa at the N-terminal side and 22 aa at the
C-terminal side accumulated at the lesion, suggesting that this
region of Dysf is sufficient for allocation to this particular
compartment. In contrast to previous cell culture studies (Idone
et al., 2008; Reddy et al., 2001), we did not observe significant
exocytic or endocytic vesicle recruitment at the lesion in the ze-
brafish myofiber.
The Role of Dysf and Annexins in Membrane Repair
Several lines of evidence suggest a late fusogenic function for
Dysf. Neither the repair membrane formation nor traffic depends
on Dysf. Extensive vesicle accumulation was described in
rupturedDysf/mousemyofibers (Bansal et al., 2003). Likewise,
our electron microscopy study revealed vesicles in damaged ze-
brafish dysf morphant myofibers. Although such vesicles were
hypothesized to represent a compensatory RAB27A pathway
(Kesari et al., 2008), we did not detect increased Rab27a traffic
toward the rupture in dysf knockdown myofibers. In contrast,
we observed unaltered DysfC decorated membrane accumula-
tion at the lesion in dysfmorphants. The MG53 protein (ortholog
not yet identified in zebrafish) was found to be essential for
plasma membrane repair and for Dysf targeting to the lesion
(Cai et al., 2009b), placing it functionally upstream of Dysf and
further supporting a late role for Dysf. Finally, we found that
Dysf can form homo-oligomers via the CEN2 region. It is likely
that multimerization of Dysf could lead to membrane fusion at
the sarcolemma in order to complete the resealing process.
The response of diverse annexins (ANXA1, ANXA2, ANXA5,
ANXA6) tomembrane lesions has recently gainedmuch attention
(Bouter et al., 2011; McNeil et al., 2006; Potez et al., 2011).
However, the data have been restricted to cell culture systems
and focused on a limited set of proteins at a time. We demon-
strate here a sequential recruitment of all annexins present in
the myofiber to the sarcolemmal lesion, where the proteins
generate adensepatch.Considering the lipid bindingcapabilities
of annexins (Gerke et al., 2005), they could, in addition to physi-
cally clogging the rupture, support Dysf in linking membrane
structures together. In favor of such a role, we detected signifi-
cantly impaired patch formation in anxa6morphants.(M) Expression of mOrange1-DysfC or Anxa6 del-mOrange1 (lacking 4 C-terminal
i36e37 or anxa6 morphants, respectively.
(N) Anxa6-mTFP1 rapid response is not perturbed in dysf i36e37 morphants.
(O) mTFP1-DysfC response to membrane damage is not affected in anxa6 morp
(P) Unperturbed mTFP1-DysfC accumulation at the site of sarcolemmal lesion in
(Q) mTFP1-DysfC accumulation at the sarcolemmal rupture (arrow) in anxa6 mor
(R) Full-length Dysf-mTFP1 is maintained at the T-tubule neck regions (arrowhead
(3 min after damage).
(S) mTFP1-DysfC accumulation at the site of sarcolemmal lesion (arrow) in dysf
(T) mTFP1-Rab27a does not respond to membrane damage (arrow) in dysf i36e37
site of lesion is indicated as percentage relative to the undamaged state (green lin
(G–J) and (Q–T) indicates site of damage.
Scale bars represent 4 mm. See also Figure S5.
DeveloThe combination of high-resolution in vivo imaging with func-
tional data allowed us to demonstrate an unexpected complexity
in the sarcolemmal patch formation. We show that, in the initial
response, Dysf-enriched membrane accumulates simulta-
neously but independently from Anxa6. In the second phase,
Anxa2a is added to the patch and finally, but several minutes
later, Anxa1a covers the lesion. The accumulation of both
Anxa1a and Anxa2a is impaired in anxa6 and dysf morphants.
It appears likely that Dysf and Anxa6 lay out the initial protein-
membrane matrix, to which other proteins are subsequently
added. In conclusion, we propose that the repair patch consti-
tutes a highly ordered scaffold, where the addition of the
following layer depends on the correct distribution of the
previous one.
EXPERIMENTAL PROCEDURES
Detailed cloning description, list of primers, in situ hybridization, and protein
purification protocols are included in the Supplemental Experimental Proce-
dures (available online). RACE PCR (FirstChoice RLM RACE kit, Ambion)
was used for obtaining full-length cDNAs of dysf and anxa6 genes.
Six morpholinos against dysf exon/intron boundaries (the number after ‘‘e’’
indicates the exon number, and the number after ‘‘i’’ indicates the intron
number: e11/i11; e18/i18; e26/i26; e31/i31; i36/e37; e43/i43) and one against
the translation start site were analyzed. Only e18/i18 (50-GTGGTATTATCT
CACCGTCGAACAC-30) and i36/e37 (50-GGCAATCGCTGAAGAGAGTGCA
GAA-30) led to changed splicing. Anxa6 morpholino (50-TCCTGCCTCATA
CAGCTCCTATAAT-30) also induced splicing change. We used 5 bp mismatch
controls (e18/i18 contr.: 50- GTCGAATTATGTCACCCTCCAACAC-30; i36/e37
contr.: 50- GGCAAACCCTGAACAGACTCCAGAA-30; mo_anxa6 contr.:
50-TCGTCCCTGATACACCTCGTATAAT-30). All morpholinos were injected at
one-cell stage at 0.8 mM concentration. For verification of splicing pattern,
total RNA was extracted from 3-day-old larvae with Trizol and RT-PCR was
carried out with SuperScript II reverse transcriptase. Gene-specific primers
were used for the following PCR. All the PCR products were cloned to
pGEM-T (Promega) and sequenced with SP6 and T7 primers.
We generated fluorescently tagged proteins by fusing them via three
sequential flexible linker motifs (Gly-Gly-Gly-Gly-Ser) to the C- or N-terminus
of mTFP1 or mOrange1. The choice of location of the tag was based on pub-
lished data or assessed empirically. C-terminal tagswere used for all annexins,
Lamp1, Lamp2, Dysf, and Cav3. An N-terminal fluorescent tag was used for all
Rab-GTPases, Laptm4a, Stx4, and SNAP23.
The zebrafish AB WT line was used for sarcolemmal damage experiments,
and thesewere carried out according to approved ethical guidelines. For in vivo
visualization, 3- to 5-day-old larvae were immobilized with 0.02% MESAB,
immersed in a water droplet on a microscopy slide and imaged with a dip-in
633 objective (NA: 0.90; HCX APOwater; Leica) and a Leica TCSSP2 confocal
microscope with Leica LCS software. The observations were performed at
22C. The sarcolemma was damaged with a two-photon laser set at
822 nm. Each protein response to membrane lesion was imaged at least 10
times. Comparative annexin kinetic properties were assessed on pairwise orCa2+-sensitive domains) do not rescue Anxa2a-mTFP1 patch formation in dysf
hants.
dysf i36e37 morphants.
phants at 60 s after damage.
) and accumulates at the site of sarcolemmal lesion (arrow) in anxa6morphants
i36e37 morphants at 3 min after damage.
morphants (3 min after damage). In all the charts (A–F, K–P), the change at the
e; mean from 6–10 experiments). Cell is outlined in white in (R) and (T). Arrow in
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curves for accumulation were based on 8–15 experiments. Error bars repre-
sent standard error of the mean in all experiments.
FRAP with mOrange1-tagged annexins was carried out in Leica fly mode:
bidirectional scanning with one image per 0.082 s at 1400 Hz. A 514 nm laser
was used for excitation, and emission was gathered between 550 and 650 nm.
Quantification was carried out in a 19.46 mm2 circular area. Twenty-five inde-
pendent FRAP measurements were employed for each annexin, and the
average kinetic parameters were calculated. For membrane proteins, the
experiment was done with 800 Hz. One frame every 2 s was recorded during
the recovery phase. The calculations were carried out on a rectangular sarco-
lemmal area (4 mm 3 1.2 mm). The experiment was repeated 10 times. FRAP
data were corrected for loss of fluorescence during recording and normalized
to prebleach intensity. Formembrane proteins, datawere further normalized to
equalize bleach level (Phair et al., 2004). For FRET experiments, proteins were
tagged with mTFP1 and mOrange1. A 458 nm laser was used for excitation,
and emission was analyzed between 610 and 700 nm. The images were
normalized for differences in the expression levels of input proteins. Each an-
nexin pair was imaged in five different cells. FRET intensity was estimated in
a 6.6 mm2 circle located at the lesion site after all the annexins had accumu-
lated at the site of lesion (5 min). We injected 0.1% Evans blue dye in Ringer
solution at 48 hpf into the pericardiac sinus and imaged at 72 hpf.
Immunohistochemistry was carried out on embryos fixed in BT-Fix solution
(4% paraformaldehyde [PFA], 4% sucrose) for 1 hr at room temperature. The
larvae were washed thereafter with PBS and 83 15 min with PBS/0.7% Triton
(or PBS/0.1% Tween for the 24 hpf stage). Larvae at 72 hpf were briefly rinsed
with water and incubated for 7 min at 20C in acetone and 1 min in water.
After an additional four washes in PBS/0.7% Triton or PBS/0.1% Tween, the
blocking solution (1% BSA, 1% dimethyl sulfoxide [DMSO], PBS) was applied
for 3 hr. Incubation with the primary antibody followed overnight at 4C. Anti-
bodies were anti-myosin heavy chain (F59; Developmental Studies Hybridoma
Bank, The University of Iowa; Crow and Stockdale, 1986) and anti-b-sarcogly-
can (Novocastra). After 8 3 15 min washes with the blocking buffer, the
anti-rabbit Alexa 594 (Invitrogen) was added and incubated for 2 hr at room
temperature. Actin was stained with phalloidin-FITC (Sigma-Aldrich).
In order to induce muscle cramps, we incubated 58-hpf-old zebrafish larvae
overnight (until 71-72 hpf) in 30 mM veratridine (Sigma-Aldrich). Of 50 treated
larvae, 5 were selected at random for electron microscopy. Larvae were fixed
overnight to 2 days at 4C in PFA and glutaraldehyde (GA) containing fixative
(2%PFA; 1.25%GA; 0.1MPIPES; 0.1%NaN3). The larvaewerewashed there-
after in 0.1 M PIPES buffer (3 3 10 min), followed by second fixation (0.1M
PIPES; 0.5%OsO4; 0.8%K3[Fe(CN)6]) at 4
Con ice. The sampleswerewashed
2 3 15 min in PIPES buffer and 2 3 15 min in water. Staining was carried out
with 2% uranyl acetate (25% ethanol, 75% water) at 4C. On the next day,
the larvae were washed 23 15 min in PIPES buffer and dehydrated in ethanol
gradient to 100% ethanol. Larvae were embedded in Epon and sectioned. A
Zeiss EM109 electron microscope was used for imaging. In each fish, at least
3 myomeres were analyzed in detail, thus covering >100 myofibers.
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